DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway
出版年份 2023 全文链接
标题
DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway
作者
关键词
-
出版物
CELLULAR SIGNALLING
Volume -, Issue -, Pages 110962
出版商
Elsevier BV
发表日期
2023-11-05
DOI
10.1016/j.cellsig.2023.110962
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- DHX38 restricts chemoresistance by regulating the alternative pre-mRNA splicing of RELL2 in pancreatic ductal adenocarcinoma
- (2023) Zeru Li et al. PLoS Genetics
- Retinitis pigmentosa-linked mutation in DHX38 modulates its splicing activity
- (2022) Mina Obuća et al. PLoS One
- EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
- (2022) Silvia La Monica Cells
- Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
- (2022) Reinhard Dummer et al. LANCET ONCOLOGY
- FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
- (2022) Yufei Long et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics
- (2022) Juhaer Anjum et al. PHARMACOLOGICAL RESEARCH
- Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
- (2022) Paolo A Ascierto et al. LANCET ONCOLOGY
- MEK inhibitors for the treatment of non-small cell lung cancer
- (2021) Jing Han et al. Journal of Hematology & Oncology
- Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa‐miR‐6887‐3p
- (2021) Haixia Li et al. Cancer Communications
- RAF-MEK-ERK pathway in cancer evolution and treatment
- (2021) Rahim Ullah et al. SEMINARS IN CANCER BIOLOGY
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy
- (2021) J. Remon et al. ANNALS OF ONCOLOGY
- Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
- (2021) Elmira Roshani Asl et al. LIFE SCIENCES
- Research Progress on the Structure and Function of G3BP
- (2021) Weifang Kang et al. Frontiers in Immunology
- Anticancer drug resistance: An update and perspective
- (2021) Ruth Nussinov et al. DRUG RESISTANCE UPDATES
- HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
- (2021) Yiwei Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation
- (2021) Wenhui Ma et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Revisiting neoadjuvant therapy in non-small-cell lung cancer
- (2021) Stephanie P L Saw et al. LANCET ONCOLOGY
- G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer
- (2021) Chandrani Mukhopadhyay et al. Nature Communications
- The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen
- (2021) Brandon Cona et al. FEBS Open Bio
- Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations
- (2020) J. Mazieres et al. ANNALS OF ONCOLOGY
- Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
- (2020) Ufuk Degirmenci et al. Cells
- G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules
- (2020) Peiguo Yang et al. CELL
- Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Ralf Gutzmer et al. LANCET
- The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
- (2020) Jimin Yuan et al. Journal of Hematology & Oncology
- Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
- (2020) Reinhard Dummer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives
- (2020) Evgeny N. Imyanitov et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Lung cancer
- (2020) Herb Brody NATURE
- KRAS-mutant non-small cell lung cancer: Converging small molecules and immune checkpoint inhibition
- (2019) Helen Adderley et al. EBioMedicine
- Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
- (2019) Kirsten L. Bryant et al. NATURE MEDICINE
- Targeting the ERK Signaling Pathway in Melanoma
- (2019) Paola Savoia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
- (2019) Micol Eleonora Fiori et al. Molecular Cancer
- Targeting ERK1/2 protein-serine/threonine kinases in human cancers
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial
- (2019) Cathy Eng et al. LANCET ONCOLOGY
- Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
- (2019) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- Telmisartan inhibits oxalate and calcium oxalate crystal-induced epithelial-mesenchymal transformation via PPAR-γ-AKT/STAT3/p38 MAPK-Snail pathway
- (2019) Yadong Liu et al. LIFE SCIENCES
- A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53
- (2018) Chao Mao et al. CANCER RESEARCH
- HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
- (2018) Lu Chen et al. Cell Death & Disease
- The roles and mechanisms of G3BP1 in tumour promotion
- (2018) Cong-Hui Zhang et al. JOURNAL OF DRUG TARGETING
- G3BP1 promotes DNA binding and activation of cGAS
- (2018) Zhao-Shan Liu et al. NATURE IMMUNOLOGY
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search